Slashdot Mirror


Combining Nanotech and Radiology

Twilight1 writes "According to this article at CNN, researchers are testing a microscopic "smart bomb" to target, attack, and kill cancer cells. It's quite fascinating that they are using radioactive by-products from the production of nuclear power and weapons as the effective payload."

2 of 125 comments (clear)

  1. Re:Normal cells by Edgy+Loner · · Score: 5, Informative

    Divison.

    Radiation, chemotherapy and the like are more likely to kill cells during division. Cancer cells divide all the time, hence are more sensitive to these agents. Most normal cells don't divide as much and aren't as senstive. Exceptions would be hthe cells that line the gi tract and form hair follicles. Which is why rad/chemotherapy tends to make people losse their hair.

  2. Reply from a cancer researcher.. by Chico+Science · · Score: 4, Informative

    I work at the National Cancer Institute and figured I'd give my personal scientific view (not official, since I'd get flayed for doing that).

    While the research *is* interesting there are a lot of caveats. The article specified that this technique has been successful in treating a broad range of cancers. In culture. This means there's cells in a flask with medium and they add the agent to the medium. This means the cancers are definitely coming in contact. In a human system, this may not be the case. An intravenous injection may not service tumors embedded in tissues. Especially brain tumors because of the blood-brain barrier.

    Another caveat. Nearly every system of targetted therapeutics involving antibodies has failed in humans, despite any remarkable results in mice. Several other wildly successful therapeutics in mice (angiogenesis inhibitors for example) are only modestly successful in humans.

    Models, be they mouse or cell culture, do not carry over terrifically well to 'in the wild' cancers in humans. Entirely possible that these treatments will have some benefit for certain cases. On the whole, this isn't the "smart bomb" or "cure for cancer" the media portrays. Unfortunately, the AP doesn't report the caveats. Also, as of yesterday, I wasn't able to find any reference to this study in medical literature. I suspect that the moment the journal it was submitted to accepted the paper, a publicist was on the phone with the press. Accordingly, the media story is in the hands of the public before the peer reviewed article is.

    Just another case of wait and see. I hope for the best, but don't expect it (sorry guys).

    Ciao, C.Sc.